|
|
|
|
|
|
|
|
|
|
MTB000019 More about MTB000019 on TBDB.org More about MTB000019 on TubercuList |
Display all mutations or select a bar from the histogram above to examine in greater detail |
| MTB000019: all mutations (high confidence mutations are highlighted in yellow) | |||||||||||||||
| Primary reference | Polymorphism | Nucleotide position | Codon position | Amino acid | Time period | Origin | Molecular detection method | Gene coverage | Resistance pattern | MIC | Susceptibility testing method | R/Total isolates | R/S isolates with mutation | Additional mutations | High confidence support |
| Ramaswamy SV J Med Micro 2004 | G/A | 189 | 189 | - | 1996-1998 | Mexico | Sequencing | Whole rrs | RHS | N.S | Proportion method | 39838 | 1/0 | "15 ups; C/T (inhA)" | - |
| Ramaswamy SV J Med Micro 2004 | G/T | 426 | 426 | - | 1996-1998 | Mexico | Sequencing | Whole rrs | RHS | N.S | Proportion method | 39838 | 1/0 | "315, AGC/ACC, Ser/Thr (katG); 450, TCG/TTG, Ser/Leu (rpoB)" | - |
| Spies FS AAC 2008 | G/C | 426 | 426 | - | Published 2008 | Brazil | Sequencing | 530 loop, 912 region | RHSE | >31,5ug/ml | Resazurin microtiter assay | 47/32 | 1/0 | "gidB: CCT/CGT; L16R" | - |
| Brzostek A IntJ TubLungDis 2004 | C/T | 461 | 461 | - | 2000 | Poland | Sequencing | 530 loop, 912 region | S | N.S | Proportion method | 4/88 | 4/0 | none | - |
| Meier A AAC 1994 | C/T | 491 | 491 | - | - | - | Sequencing | Whole rrs | HS | N.S | Proportion method | 3/38 | 1/0 | - | ![]() |
| Meier A AAC 1994 | C/T | 512 | 512 | - | - | - | Sequencing | "505 bp gene fragment; complete S12 gene" | RHS | N.S | Proportion method | 3/38 | 1/0 | - | ![]() |
| Honore N AAC 1995 | ins C | 512 | 512 | Frameshift | - | - | - | - | N.S | N.S | - | - | - | - | - |
| Dobner P MolCellProbes 1997 | A/C | 513 | 513 | - | 1996 | Germany, Sierra Leone | Sequencing | 530 loop, 912 region | S | N.S | - | 1/50 | 1/0 | AAG/AGG, 43 Lys/Arg (rpsL) | ![]() |
| Katsukawa C J Appl Micro 1997 | A/T | 513 | 513 | - | 1992-1994 | Japan | Sequencing | 450-944 | S | 20-200ug/ml | Absolute concentration method | 95/172 | 9/0 | - | ![]() |
| Dobner P MolCellProbes 1997 | C/T | 516 | 516 | - | 1996 | Germany, Sierra Leone | Sequencing | 530 loop, 912 region | S | N.S | - | 1/50 | 1/0 | none | ![]() |
| Brzostek A IntJ TubLungDis 2004 | G/C | 627 | 627 | - | 2000 | Poland | Sequencing | 530 loop, 912 region | S | N.S | Proportion method, BACTEC 460 | 1/88 | 1/0 | none | - |
| Sreevatsan S AAC 1996 | C/T | 798 | 798 | - | 1995 | USA | Sequencing | 530 loop, 912 region | S | N.S | Proportion method, BACTEC 460 | 39814 | 1/0 | "only NY isolate with both rrs and rpsL (AAG/AGG; K43-->R) mutations " | - |
| Cooksey RC, AAC 1996 | C/G | 865 | 865 | - | 1994 | USA | Sequencing | 306 bp | RHS | 10 | Agar dilution method | 45/367 | 1/0 | none | - |
| Okamoto S MolMicro 2007 | G/A | 887 | 887 | - | Before 2000 | Japan | Sequencing | - | R, H, S, E, K, PAS | 20 ug/ml | Absolute concentration method | 57/132 | 1/0 | A276C, T563G (gidB) | - |
| Honore N AAC 1994 | C/A | 904 | 904 | - | 1994 | N.S. | PCR-SSCP | 530 loop, 912 region | SH | >1280 | Agar dilution method | 39974 | 1/0 | none | - |
| Honore N AAC 1994 | C/G | 904 | 904 | - | - | - | PCR-SSCP | 530 loop, 912 region | SHR | 160 | Agar dilution method | 39974 | 1/0 | none | - |
| Dobner P MolCellProbes 1997 | A/G | 905 | 905 | - | 1996 | Germany, Sierra Leone | Sequencing | 530 loop, 912 region | S | N.S | - | 1/50 | 1/0 | AAG/CAG, 88 Lys/Thr (rpsL) | - |
| Dobner P MolCellProbes 1997 | A/T | 906 | 906 | - | 1996 | Germany, Sierra Leone | Sequencing | 530 loop, 912 region | S | N.S | - | 1/50 | 1/0 | none | - |
| Katsukawa C J Appl Micro 1997 | A/C | 906 | 906 | - | 1992-1994 | Japan | Sequencing | 450-944 | S | 20-200ug/ml | Absolute concentration method | 95/172 | 1/0 | - | ![]() |
| Katsukawa C J Appl Micro 1997 | A/G | 907 | 907 | - | 1992-1994 | Japan | Sequencing | 450-944 | S | 20-200ug/ml | Absolute concentration method | 95/172 | 1/0 | - | - |
| Katsukawa C J Appl Micro 1997 | ins T | 907-908 | 907 | Frameshift | 1992-1994 | Japan | Sequencing | 450-944 | S | 20-200ug/ml | Absolute concentration method | 95/172 | 1/0 | - | - |
| Sekigushi J JCM 2007 | ins C | 1061 | 1061 | Frameshift | 2006 | Japan | Multiplex PCR | 530 loop, 912 region | N.S | N.S | Proportion method, Rapid broth method | 55/138 | 1/0 | Lys121Lys (rpsL), silent mutation, not assoc w/ STR-res. | - |
| Ramaswamy SV J Med Micro 2004 | T/C | 1238 | 1238 | - | 1996-1998 | Mexico | Sequencing | Whole rrs | RHSE | N.S | Proportion method | 39897 | 3/0 | "315, AGC/ACC, Ser/Thr (katG); 435, GAC/GTC, Asp/Val (rpoB); 43, AAG/AGG, Lys/Arg (rpsL); 306, ATG/CTG, Met/Leu (embB)" | - |
| Sekigushi J JCM 2007 | A/G | 1400 | 1400 | - | 2006 | Japan | Multiplex PCR | 428-1737 | N.S | N.S | Proportion method, Rapid broth method | 55/138 | 1/0 | Lys121Lys (rpsL), silent mutation, not assoc w/ STR-res. | - |
| Sekigushi J JCM 2007 | A/G | 1539 | 1539 | - | 2006 | Japan | Multiplex PCR | 428-1737 | N.S | N.S | Proportion method, Rapid broth method | 55/138 | 1/0 | "A1400G (rrs); Lys121Lys (rpsL), silent mutation, not assoc w/ STR-res." | - |
Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations. |
|
© 2010 Andreas Sandgren | Supported by the Swedish Research Council | Contact Database Curator |